Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of a combination of Dbait molecule and PARP inhibitors to treat cancer

Use of a combination of Dbait molecule and PARP inhibitors to treat cancer

US Patent 11162095 · Granted Nov 2, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of cancer by systemic administration of Dbait molecules2020
Optimized in vivo delivery system with endosomolytic agents for nucleic acid con2020
Use of a combination of Dbait molecule and PARP inhibitors to treat cancer2020
Use of a combination of Dbait molecule and PARP inhibitors to treat cancer2020
Optimized in vivo delivery system with endosomolytic agents for nucleic acid con2019
Optimized in vivo delivery system with endosomolytic agents for nucleic acid con2017
Optimized in vivo delivery system with endosomolytic agents for nucleic acid con2016
Optimized in vivo delivery system with endosomolytic agents for nucleic acid con2015
Cancer treatment by combining DNA molecules mimicking double strand breaks with 2015
Dbait and standalone uses thereof2012
DBAIT and uses thereof2010
Nucleic acids useful for triggering tumor cell lethality2009